These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 20068179)
1. Oncogenic B-Raf(V600E) induces spindle abnormalities, supernumerary centrosomes, and aneuploidy in human melanocytic cells. Cui Y; Borysova MK; Johnson JO; Guadagno TM Cancer Res; 2010 Jan; 70(2):675-84. PubMed ID: 20068179 [TBL] [Abstract][Full Text] [Related]
2. B-Raf(V600E) signaling deregulates the mitotic spindle checkpoint through stabilizing Mps1 levels in melanoma cells. Cui Y; Guadagno TM Oncogene; 2008 May; 27(22):3122-33. PubMed ID: 18071315 [TBL] [Abstract][Full Text] [Related]
3. RKTG sequesters B-Raf to the Golgi apparatus and inhibits the proliferation and tumorigenicity of human malignant melanoma cells. Fan F; Feng L; He J; Wang X; Jiang X; Zhang Y; Wang Z; Chen Y Carcinogenesis; 2008 Jun; 29(6):1157-63. PubMed ID: 18515281 [TBL] [Abstract][Full Text] [Related]
4. C-Raf inhibits MAPK activation and transformation by B-Raf(V600E). Karreth FA; DeNicola GM; Winter SP; Tuveson DA Mol Cell; 2009 Nov; 36(3):477-86. PubMed ID: 19917255 [TBL] [Abstract][Full Text] [Related]
5. Oncogenic B-Raf(V600E) abrogates the AKT/B-Raf/Mps1 interaction in melanoma cells. Zhang L; Shi R; He C; Cheng C; Song B; Cui H; Zhang Y; Zhao Z; Bi Y; Yang X; Miao X; Guo J; Chen X; Wang J; Li Y; Cheng X; Liu J; Cui Y Cancer Lett; 2013 Aug; 337(1):125-32. PubMed ID: 23726842 [TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of Mps1 by BRAFV600E prevents Mps1 degradation and contributes to chromosome instability in melanoma. Liu J; Cheng X; Zhang Y; Li S; Cui H; Zhang L; Shi R; Zhao Z; He C; Wang C; Zhao H; Zhang C; Fisk HA; Guadagno TM; Cui Y Oncogene; 2013 Feb; 32(6):713-23. PubMed ID: 22430208 [TBL] [Abstract][Full Text] [Related]
7. Human melanoma cells expressing V600E B-RAF are susceptible to IGF1R targeting by small interfering RNAs. Yeh AH; Bohula EA; Macaulay VM Oncogene; 2006 Oct; 25(50):6574-81. PubMed ID: 16715137 [TBL] [Abstract][Full Text] [Related]
8. Differential sensitivity of melanoma cell lines with differing B-Raf mutational status to the new oncogenic B-Raf kinase inhibitor UI-152. Kim YK; Ahn SK; Lee M Cancer Lett; 2012 Jul; 320(2):215-24. PubMed ID: 22425959 [TBL] [Abstract][Full Text] [Related]
9. Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation. Wellbrock C; Marais R J Cell Biol; 2005 Aug; 170(5):703-8. PubMed ID: 16129781 [TBL] [Abstract][Full Text] [Related]
10. SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant. Tsavachidou D; Coleman ML; Athanasiadis G; Li S; Licht JD; Olson MF; Weber BL Cancer Res; 2004 Aug; 64(16):5556-9. PubMed ID: 15313890 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of the oncogenic kinase Pim-1 leads to genomic instability. Roh M; Gary B; Song C; Said-Al-Naief N; Tousson A; Kraft A; Eltoum IE; Abdulkadir SA Cancer Res; 2003 Dec; 63(23):8079-84. PubMed ID: 14678956 [TBL] [Abstract][Full Text] [Related]
12. Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors. Sharma A; Trivedi NR; Zimmerman MA; Tuveson DA; Smith CD; Robertson GP Cancer Res; 2005 Mar; 65(6):2412-21. PubMed ID: 15781657 [TBL] [Abstract][Full Text] [Related]
13. Pyrophosphorolysis detects B-RAF mutations in primary uveal melanoma. Maat W; Kilic E; Luyten GP; de Klein A; Jager MJ; Gruis NA; Van der Velden PA Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):23-7. PubMed ID: 18172070 [TBL] [Abstract][Full Text] [Related]
15. Role of the mitogen-activated protein kinase signaling pathway in the regulation of human melanocytic antigen expression. Kono M; Dunn IS; Durda PJ; Butera D; Rose LB; Haggerty TJ; Benson EM; Kurnick JT Mol Cancer Res; 2006 Oct; 4(10):779-92. PubMed ID: 17050671 [TBL] [Abstract][Full Text] [Related]